FUTR BIO


FUTR BIO is a biotechnology company focused on developing next generation mRNA vaccines to prevent and cure diseases such as infections and cancer. They harness the immune system to create revolutionary single dose vaccines with faster protective immune responses for humans and animals, utilizing a novel platform that transforms mRNA into more effective vaccines. Their proprietary technology incorporates natural UTRs and molecular boosters to provide superior immune responses, aiming to take mRNA vaccines to the next level with nature-inspired, flexible, customizable, precise, and faster protection solutions.

Industries

biotechnology

Nr. of Employees

small (1-50)

FUTR BIO

Florianópolis, Santa Catarina, Brazil, South America


Products

Next-generation mRNA vaccine platform

A company-developed mRNA vaccine platform that incorporates natural UTR sequences and molecular boosting elements to modify expression and immune activation, intended for prevention and treatment of infectious diseases and cancer.


Services

mRNA vaccine research and platform development (collaborative R&D)

Research and development of mRNA vaccine constructs and platform capabilities for infectious disease and cancer indications, including design of constructs and preclinical immunological evaluation.

Expertise Areas

  • mRNA vaccine development
  • Immunology and immune response modulation
  • Molecular virology and host-pathogen interactions
  • Structural biology
  • Show More (2)

Key Technologies

  • mRNA constructs with engineered untranslated regions (UTRs)
  • Molecular immune-boosting elements (adjuvant-like components)
  • CRISPR gene-editing tools
  • Structural biology methods
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.